VAS
RMD icon

Vestmark Advisory Solutions’s ResMed RMD Stock Holding History

Vestmark Advisory Solutions’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,172
Closed -$256K – 872
2022
Q3 		$256K Buy
1,172
+62
+6% +$14.1K 0.01% 715
2022
Q2 		$233K Buy
+1,110
New +$236K 0.01% 769
2021
Q4 		– Sell
-1,193
Closed -$314K – 868
2021
Q3 		$314K Buy
1,193
+367
+44% +$100K 0.02% 652
2021
Q2 		$204K Buy
+826
New +$174K 0.01% 750

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Vestmark Advisory Solutions's RMD Position: Q4 2022 in Review

Vestmark Advisory Solutions sold out of ResMed (RMD) in Q4 2022, closing a stake of 1,172 shares — an estimated $256K sold.

Vestmark Advisory Solutions first reported a position in RMD in Q2 2021 and held it in 4 quarters. The position peaked at $314K in Q3 2021. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • Vestmark Advisory Solutions reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 1,172 ResMed shares in Q4 2022, an estimated $256K.
  • Vestmark Advisory Solutions first reported a position in ResMed in Q2 2021 and held it in 4 quarters.
  • Vestmark Advisory Solutions's ResMed position peaked at $314K in Q3 2021.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Vestmark Advisory Solutions's 13F filing for Q4 2022, filed 20 Jan 2023.